Peng Li

This inventor holds 61 USPTO granted patents and 25 published patent applications and 32 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merck Sharp + Dohme Corp., Rhodia Operations, Telefonaktiebolaget Lm Ericsson (Publ). Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peng Li. Retrieved from https://idiyas.com/inventor/peng-li-c7rr8ak6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 61 (Patent Applications = 25)

% Patents Active = 83.6

EPO Patents = 32 (Patent Applications = 57)

Average Co-Inventor Count = 4.4

ph-index = 3

Forward Citations = 49(Granted Patents)

Forward Citations (Not Self Cited) = 37(Dec 10, 2025)

Company Filing History:

8 out of 2,405

Merck Sharp + Dohme Corp.

Telefonaktiebolaget Lm Ericsson (Publ)

patents

4. 5 out of 530

Tyco Electronics (Shanghai) Co., Ltd.

patents

5. 4 out of 3,358

Chinese Academy of Sciences

patents

6. 4 out of 13

Guangdong Raynovent Biotech Co., Ltd.

patents

7. 4 out of 8

Zhuhai United Laboratories Co., Ltd.

patents

8. 2 out of 209

Baoshan Iron & Steel Co., Ltd.

patents

9. 2 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

10. 2 out of 72

Medshine Discovery Inc.

Breakthrough Pharmaceuticals Inc.

patent

13. 1 out of 23

Chengdu Tianma Micro-Electronics Co., Ltd.

patents

14. 1 out of 7

Cisen Pharmaceutical Co., Ltd.

patents

15. 1 out of 32

Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.

patents

16. 1 out of 488

Dow Silicones Corporation

patents

17. 1 out of 7

Fujian Akeylink Biotechnology Co., Ltd.

patents

18. 1 out of 52,387

General Electric Company

patents

19. 1 out of 4

Guangzhou Joyo Pharmatech Co., Ltd.

patents

20. 1 out of 4

Harbin Zhenbao Pharmaceutical Co., Ltd.

patents

21. 1 out of 16,049

Honeywell International Inc.

Shandong Danhong Pharmaceutical Co., Ltd.

patents

24. 1 out of 1

Shanghai Cas Shenglonda Biotech (Group) Co., Ltd.

patent

25. 1 out of 1

Shanghai Zhonglian Technologies Ltd., Co

patent

26. 1 out of 3

Sharkgulf Technology (Qingdao) Co., Ltd.

patents

27. 1 out of 283

Via Alliance Semiconductor Co., Ltd.

patents

28. 1 out of 4

Wuxi Fortune Pharmaceutical Co., Ltd

patents

29. 1 out of 1

Zhuhai United Laboratories Co., Ltd.

patent

30. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Aminopyridine Compound

Tetrahydropyrrolocyclic Compound

Fused Ring Derivatives

ROS1 Inhibitor

Retinal Diseases

Pyrimidine Derivatives

FXR Agonist

SSAO Inhibitor

Wavefront Aberration

Liquid Crystal

Electro-Generative Process

Aromatic Compounds

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12662576 - Method for producing organopolysiloxane (2026-06-23),

2. 12595259 - Aminopyridine compound (2026-04-07),

3. 12583841 - Tetrahydropyrrolocyclic compound and application thereof (2026-03-24),

4. 12516070 - Fused ring derivatives and use thereof in pharmacy (2026-01-06),

5. 12497412 - Compound as highly selective ROS1 inhibitor and use thereof (2025-12-16),

6. 12479823 - Compound for use in retinal diseases (2025-11-25),

7. 12473258 - Crystal form of pyridinylphenyl compound and preparation method therefor (2025-11-18),

8. 12432126 - Method and apparatus for service management (2025-09-30),

9. 12428091 - Early-warning system, method and device for steering of two-wheeled vehicle, and corresponding two-wheeled vehicle (2025-09-30),

10. 12351587 - Bicyclic compound as RIP-1 kinase inhibitor and application thereof (2025-07-08),

11. 12319692 - Anti-influenza virus pyrimidine derivatives (2025-06-03),

12. 12231507 - Method and apparatus for flow control (2025-02-18),

13. 12215098 - Solid form, crystalline form, and crystal form a of FXR agonist, and preparation method and application thereof (2025-02-04),

14. 12116367 - Ring-modified proline short peptide compound and use thereof (2024-10-15),

15. 12077513 - Process route of compound of formula (IV), crystal form and preparation method therefor (2024-09-03),

Title: The Inventor Extraordinaire: Peng Li

Introduction:

Peng Li, a prolific inventor hailing from Shanghai, China, has secured an impressive 45 patents over the course of his career. His innovative spirit and dedication to pushing the boundaries of technology have led to groundbreaking advancements in various fields.

Latest Patents:

Among Peng Li's latest patents is a revolutionary compound designed for use in treating retinal diseases. This compound, represented by formula (II) or a pharmaceutically acceptable salt, offers new hope for individuals battling such ailments. Additionally, Peng Li has patented a method for routing communication in telecommunications networks, particularly useful in scenarios with multiple service communication proxies.

Career Highlights:

Peng Li has made significant contributions during his tenure at companies such as Merck Sharp & Dohme Corporation and Rhodia Operations. His expertise and ingenuity have played a pivotal role in developing cutting-edge solutions that have redefined industry standards.

Collaborations:

Throughout his career, Peng Li has collaborated closely with esteemed coworkers such as Xuanjia Peng and Jian Li. Together, they have synergized their talents to solve complex challenges and drive innovation forward.

Conclusion:

In conclusion, Peng Li stands as a beacon of creativity and excellence in the world of invention. His groundbreaking patents and collaborative efforts underscore his relentless pursuit of progress and his commitment to making a lasting impact on the technological landscape.

Profile summary based on public USPTO records.